The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain.
Using domain switch chimeric antibodies, we confirm the important role of CH2 in complement activation. In addition, we demonstrate that the structures responsible for the differential ability of human IgG1 and IgG4 to activate complement are located at the COOH-terminal part (from residue 292 to 340) of the CH2 domain. The amino acids in CH2 that might be involved in complement interaction are discussed. While CH3 contributes to efficient complement activation, CH3 from IgG2 and CH3 IgG3 are equally effective.
Tao
M H
MH
Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
Canfield
S M
SM
Morrison
S L
SL
D003167:Complement Activation; D006801:Humans; D007074:Immunoglobulin G / Q000235:genetics / Q000276:immunology*; D066298:In Vitro Techniques; D008958:Models, Molecular; D011993:Recombinant Fusion Proteins; D013329:Structure-Activity Relationship
D007074:Immunoglobulin G; D011993:Recombinant Fusion Proteins